Dermatomyositis — RCPSC IM MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Undertake age-indicated and risk-directed malignancy evaluation
The best answer is “Undertake age-indicated and risk-directed malignancy evaluation”. Dermatomyositis, especially with anti-TIF1-gamma, carries increased malignancy risk. Screening is individualized by age, phenotype and antibody profile while muscle and swallowing disease is treated. Dysphagia also requires urgent aspiration-risk assessment because respiratory and swallowing complications can become more immediate than muscle weakness.
Reference: Canadian Rheumatology Association, clinical guidelines: https://rheum.ca/resources/publications/